ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SHP Shire

4,690.00
0.00 (0.00%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shire LSE:SHP London Ordinary Share JE00B2QKY057 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4,690.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Shire Share Discussion Threads

Showing 2476 to 2499 of 5350 messages
Chat Pages: Latest  106  105  104  103  102  101  100  99  98  97  96  95  Older
DateSubjectAuthorDiscuss
25/10/2017
18:52
Yes, I get that feeling as well steeplejack :-S
philanderer
25/10/2017
18:19
I wouldn't be surprised if we didn't get a good clobbering on Friday.I feel the share wants to overshoot on the downside and become silly cheap before it rebounds.Its just a hunch but since I have no intention of selling,I'll just be irritated rather than overly concerned.
steeplejack
25/10/2017
17:35
Thanks Phil, I'm over 60% in cash currently. Even bought some gold earlier today-PHCP.
essentialinvestor
25/10/2017
17:30
I'm more nervous on markets in general atm, US in particular looks toppy.

On Shire, net debt would not concern me with current FCF, GSK would
kill for Shires FCF.

The market appears fixiated on generic and competitor risk with SHP atm.
Whether rightly or wrongly, might become a little clearer on Friday

essentialinvestor
25/10/2017
16:50
Know what you mean EI!
toffeeman
25/10/2017
16:46
Think I found at least a partial reason for the GSK dive,
The CEO's comments today about being .. a consolidator in the fragmented
consumer products market. And they may be interested in Merck's OTC business


Had a very small amount of Shire at 36.05, promised myself I would not,
probably regret it.
.

essentialinvestor
25/10/2017
16:33
Poodle FTSE follows the DOW down when it plummets but barely rose itself when the DOW was on a tear this month. Disgraceful BS.
justiceforthemany
25/10/2017
16:24
With the speed SHP and the FTSE has turned, I will lower my buy price! Not in yet, at least my FTSE short is bearing fruit, some compensation when my portfolio is being battered!
andyj
25/10/2017
16:22
andyj was waiting for 3600p so he'll be in now as well.

Luck to all.

philanderer
25/10/2017
16:10
In at 36.0175 - stop loss at 34.5
toffeeman
25/10/2017
16:08
Getting tempted here....
toffeeman
25/10/2017
15:50
I hope we're not going to mimic GSK on Friday.
steeplejack
25/10/2017
14:36
The share price suggests that a takeover/merger would be welcomed at this point in time
mbmiah
25/10/2017
13:50
So even in a 'worst-case' scenario Shire should be trading around 4500p. Quite a discount then.
justiceforthemany
25/10/2017
13:47
Credit Suisse Slashes Shire Target Price, Says Discount To Peers "Unjustified"


Shire's current discount to its global sector peers is unjustified, even under a worst case scenario for haemophilia and hereditary angiodema, Credit Suisse argues.

In a research report published on Wednesday, the analysts said the shares were then trading at a roughly 40% discount in terms of the price-to-earnings multiple, amid suggestions that so-called 'sell-side forecasts are "unrealistic".

Yet even after revisiting its own estimates for Xidra, lowering its assumptions for the HAE franchise, assuming faster erosion from competition for Lialda and lowering its haemophilia numbers, it found that the shares should be trading 23% higher.

Specifically, the Swiss broker dropped its projections for the company's 2020 revenues and earnings per share by 8% and 15%, pushing their estimate of net asset value from 5590p to 5190p and the target price from 5350p to 4500p.

The theoretical upside in the share price as implied by its estimates held true even under worst case scenarios for haemophilia and HAE erosion.

Hence, Credit Suisse stuck by its 'outperform' recommendation on the stock.

"We conclude that, despite all the recent setbacks and uncertainty, the current valuation effectively eliminates haemophilia, Xiidra & HAE income."

philanderer
25/10/2017
13:47
edit: double post :-)
philanderer
25/10/2017
09:57
Just keep waiting, you'll make lots of money
mbmiah
25/10/2017
08:09
Buy at 3600 or wait for 3500?
toffeeman
24/10/2017
16:11
Thanks for the reply fozzy , luck with those.

Agree justice , way under that 5000p should do now.

philanderer
24/10/2017
15:57
Vulnerable to an imminent hostile bid like Spire this week. Ornskov fed up. Will sell up IMO. Activists and shareholders fuming. Even mid 40's will get the job done now.
justiceforthemany
24/10/2017
15:34
Best of luck.
essentialinvestor
24/10/2017
15:33
I had a limit at 3633 that got filled, if you ask why there, it's because I thought it possible. I often set limits way below spot pricing and take advantage of what I see as value which is challenging in this market.That being said my average position is still late 30s so this is an average down, but happy to hold. I will put a further limit in at £33 just in case as long term I believe this is undervalued, and happy to hold for a number of years.
fozzyb
24/10/2017
14:39
This share price performance,we're not far above a three low,makes the Baxalta acquisition look like an error of judgement.On Friday,the management are going to have to make a very good apologia as to why the market is an idiot and why the company is a snip at these prices.First and foremost,analysts will scour the results looking for anything that might vindicate the weakness in the share price.In that context,it's anyone's bet whether the shares slump further or enjoy a sharp recovery.I lost touch with the thinking behind this share when they broke down through £40.
steeplejack
24/10/2017
14:22
I'm always intrigued when people give an exact target buy price.

So on £36, you would not buy at 36.05, or 36.01 ?.

essentialinvestor
Chat Pages: Latest  106  105  104  103  102  101  100  99  98  97  96  95  Older

Your Recent History

Delayed Upgrade Clock